Utility of flow cytometric detection of CD69 expression as a rapid method for determining poly- and oligoclonal lymphocyte activation

CD69 is a lymphoid activation antigen whose rapid expression (< or = 2 h postactivation) makes it amenable for the early detection of T-cell activation and for subset activation analyses. In the present study we evaluated the utility of flow cytometric detection of CD69 expression by T cells activated with polyclonal stimuli (anti-CD3 and staphylococcal enterotoxin B [SEB]) and oligoclonal stimuli (tetanus toxoid and allogeneic cells) using flow cytometry. Following activation of T cells with anti-CD3 or SEB, CD69 is detectable at < or = 4 h following activation, with anti-CD3 peaks at 18 to 48 h. Dose titration experiments indicated that CD69 expression largely paralleled that in [3H]thymidine incorporation assays, although the former offered a more sensitive measure of T-cell activation at limiting doses of activator than [3H]thymidine incorporation when cells were activated with either anti-CD3 or SEB. However, activation of T cells with either tetanus toxoid or allogeneic stimulator cells failed to induce detectable CD69 expression at up to 7 days of culture. Subset analyses of anti-CD3- and SEB-activated T cells indicated that populations other than T cells can express CD69 following stimulation with T-cell-specific stimuli, indicating that CD69 can be induced indirectly in non-T cells present in the population. These findings indicate that CD69 is a useful marker for quantifying T-cell and T-cell subset activation in mixed populations but that its utility might be restricted to potent stimuli that are characterized by their ability to activate large numbers of cells with rapid kinetics.

[1]  V. Maino,et al.  Rapid flow cytometric method for measuring lymphocyte subset activation. , 1995, Cytometry.

[2]  R. Testi,et al.  Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors , 1994, The Journal of experimental medicine.

[3]  R. Testi,et al.  Involvement of p21ras activation in T cell CD69 expression , 1994, European journal of immunology.

[4]  G. Trinchieri,et al.  Differential effects of tyrosine kinase inhibition in CD69 antigen expression and lytic activity induced by rIL-2, rIL-12, and rIFN-alpha in human NK cells. , 1993, Cellular immunology.

[5]  J. Ceuppens,et al.  Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism. , 1993, Immunology.

[6]  P. Marrack,et al.  Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[7]  P. Marrack,et al.  V beta-specific stimulation of human T cells by staphylococcal toxins. , 1989, Science.

[8]  J. Redondo,et al.  Expression and function of AIM, an activation inducer molecule of human lymphocytes, is dependent on the activation of protein kinase C , 1989, European journal of immunology.

[9]  R. Testi,et al.  Leu 23 induction as an early marker of functional CD3/T cell antigen receptor triggering. Requirement for receptor cross-linking, prolonged elevation of intracellular [Ca++] and stimulation of protein kinase C. , 1989, Journal of immunology.

[10]  C. Janeway,et al.  T‐Cell Responses to Mls and to Bacterial Proteins that Mimic its Behavior # , 1989, Immunological reviews.

[11]  L. Lanier,et al.  Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen , 1988, The Journal of experimental medicine.

[12]  R. Fisher,et al.  In vivo effects of recombinant IL-2. I. Isolation of circulating Leu-19+ lymphokine-activated killer effector cells from cancer patients receiving recombinant IL-2. , 1988, Journal of immunology.

[13]  S. Fu,et al.  Human T cell activation. III. Rapid induction of a phosphorylated 28 kD/32 kD disulfide-linked early activation antigen (EA 1) by 12-o- tetradecanoyl phorbol-13-acetate, mitogens, and antigens , 1986, The Journal of experimental medicine.

[14]  S. Ziegler,et al.  The activation antigen CD69 , 1994, Stem cells.